ExpreS2ion Biotech Holding AB (5JD0) Financial Statements
ExpreS2ion Biotech Holding AB Financial Overview
ExpreS2ion Biotech Holding AB's market cap is currently $3.36M. The company's EPS TTM is $-6.83; its P/E ratio is -0.14; ExpreS2ion Biotech Holding AB has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 3.66M | $ 3.01M | $ 7.05M | $ 5.09M | $ 12.23M |
| Gross Profit | $ -42.84M | $ -2.67M | $ 3.40M | $ 5.00K | $ 4.72M |
| Operating Income | $ -52.82M | $ -67.69M | $ -105.97M | $ -127.61M | $ -48.40M |
| EBITDA | $ -51.35M | $ -64.34M | $ -102.45M | $ -124.49M | $ -46.38M |
| Net Income | $ -38.09M | $ -36.04M | $ -91.40M | $ -118.61M | $ -43.92M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 47.55M | $ 81.54M | $ 57.60M | $ 110.97M | $ 138.88M |
| Total Assets | $ 65.11M | $ 104.53M | $ 78.69M | $ 137.36M | $ 151.96M |
| Total Debt | $ 2.21M | $ 1.80M | $ 1.71M | $ 1.85M | $ 2.11M |
| Net Debt | $ -45.35M | $ -79.74M | $ -55.89M | $ -109.12M | $ -35.19M |
| Total Liabilities | $ 29.42M | $ 40.11M | $ 13.33M | $ 34.04M | $ 11.61M |
| Stockholders' Equity | $ 35.69M | $ 64.80M | $ 65.36M | $ 103.33M | $ 140.35M |
| Cash Flow | |||||
| Free Cash Flow | $ -40.90M | $ -34.80M | $ -102.90M | $ -100.00M | $ -46.36M |
| Operating Cash Flow | $ -40.90M | $ -33.93M | $ -100.89M | $ -99.61M | $ -45.65M |
| Investing Cash Flow | $ 0.00 | $ 21.27M | $ -2.02M | $ 105.33M | $ -100.92M |
| Financing Cash Flow | $ 10.78M | $ 34.87M | $ 47.84M | $ 61.46M | $ 74.55M |
Currency in SEK
